Histological and histometric aspects of radicular dentinogenesis in upper first molars of fluoxetine treated rats / Aspectos histológicos e histométricos da dentinogênese radicular em primeiros molares superiores dos ratos tratados com fluoxetina
DOI:
https://doi.org/10.34119/bjhrv3n2-131Keywords:
Fluoxetine, Dental Germ, SerotoninAbstract
Introduction: Serotonin is a neurotransmitter implicated on the control of several bodies roles including the regulation of circadian rhythm, of sleepiness, body temperature, motor and cognitive activities and of growth and development of tissues during embryogenesis. Objective: The aim of the present study is to assay the morphological aspects of the root dentin of upper first molars from pups of rats that were treated with fluoxetine in pregnancy. Methodology: For such, we conducted a random experimental study by using used 12 Wistar pregnant rats divided into three groups: C, FX and FL group. From the first to the 21 day of pregnancy, the rats received saline solution or fluoxetine hydrochloride solution, subcutaneously, according to the group to which they belonged. Subsequently, the offspring of animals was divided into subsets according to the age of tooth germ development to be studied: C20 and C45 (control group of 20 and 45 days of age); FL20 and FL45 (treated group with fluoxetine 10 mg/kg body weight of 20 and 45 days of life) and FX20 and FX45 (treated group with fluoxetine 20 mg/kg body weight of 20 and 45 days old). The thickness of root dentin, predentin thickness and length of odontoblasts were analyzed at the offspring samples. The data were tabulated and statistical values were performed with a significance level p < 0,05. Results/Conclusion: Studies have shown significant changes in dentinogenesis root of the groups treated with fluoxetine at doses of 10 and 20 mg / kg body weight during pregnancy.
References
Battaglino, R., Vokes, M., Schulze-Späte, U., Sharma, A., Graves, D., Kohler, T., Müller, R., Yoganathan, S., Stashenko, P., 2007. Fluoxetine treatment increases trabecular bone. J Cel Bioc. 100, 1387–1394. DOI: 10.1002/jcb.21131.
Berle J.O., Spigset O., 2011. Antidepressant use during breastfeeding. Curr Women’s Health Rev. 7, 28-34. DOI: 10.2174 / 157340411794474784.
Cavalcanti, U. D. N. T., Baratella-Evêncio, L., Neto, J. E., Castro, R. M., Cardona, A. S., Melo, M. L. M., Lins, R. C., 2009. Morphological aspects of the embryonic development of the TMJ in rats (Rattus norvegicus albinus) treated with fluoxetine. Int J Morphol. 27, 899-903. DOI: 10.4067/S0717-95022009000300041.
Correia-Leite de Marcelos, P. G., Regueira, L. S., Santiago-Jaegger, I. M., Perez, D. E. C., Ramos-Perez, F. M. M., Neto, J. E., Baratella-Evêncio, L., 2015. Effects of treatment with fluoxetine on mandibular development: a morphological study in rats. Acta Histochem. 117, 582-589. DOI: 10.1016/j.acthis.2015.05.005.
Duffy, L., Bacon, F., Clarke, C. S., Donkor, Y., Freemantle, N., Gilbody, S., Hunter, R., Kendrick, T., Kessler, D., King, M., Lanham, P., Lewis, G., Mangin, D., Marston, L., Moore, M., Nazareth, I., Wiles, N., Lewis, G., 2019. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent relapse in depression): study protocol for a randomised controlled trial. Trials. 20, 319-31. DOI: https://doi.org/10.1186/s13063-019-3390-8.
Düsman, E., Almeida, I. V., Mariucci, R. G., Mantovani, M. S., Vicentini, V. E. P., 2014. Cytotoxicity and mutagenicity of fluoxetine hydrochloride (Prozac), with or without vitamins A and C, in plant and animal model systems. Genet Mol Res. 13, 578-89. DOI: http://dx.doi.org/10.4238/2014.January.28.3.
Dzevlan, A., Redzepagic, R., Hadzisalihovic, M., Curevac, A., Masic, E., Alisahovic-Gelo, E., Merdzanovic, E., Hadzimuratovic. A., 2019. Quality of Life Assessment in Antidepressant Treatment of Patients with Depression and/or Anxiety Disorder. Mater Sociomed. 31, 14-18. DOI: 10.5455/msm.2019.31.14-18.
Galli, C., Macaluso, G., Passeri, G., 2013. Serotonin: a novel bone mass controller may have implications for alveolar bone. J Negat Results Biomed. 12, 12-17. DOI: 10.1186 / 1477-5751-12-12.
Hendrick, V. M. D., Altshuler, L. M. D., 2002. Management of major depression during pregnancy. Am J Psychiatry. 159, 1667-1673. DOI: DOI: 10.1176 / appi.ajp.159.10.1667.
Hendrick, V. M. D., Altshuler, L. M. D., Zachary, N., Stowe, M. D., Sun Hwang, M. S., Emily Lee, B. A., Desiree Haynes, M. S., 2003. Placental passage of antidepressant medications. Am J Psychiatry. 160, 993–996. DOI: DOI: 10.1176 / appi.ajp.160.5.993.
Imai, R., Miake, Y., Yanagisawa, T., Yakushiji, M., 2007. Grow and formation of the tooth germ in a rat model of fetal alcohol syndrome. J Hard Tis Bio. 16, 61-70. DOI: https://doi.org/10.2485/jhtb.16.61.
Jaques-Belik, M. D., 2008. Fetal and neonatal effects of maternal drug treatment for depression. Semin. Perinatol. 32, 350-354. DOI: 10.1053/j.semperi.2008.08.001.
Kameyama, Y., 1973. The pattern of alveolar bone activity during development and eruption of the molar in the rat. J Periodont Res. 8, 179-191. DOI: https://doi.org/10.1111/j.1600-0765.1973.tb01756.x.
Koura, S. M., Salama, M., El Hussiny, M., Khalil, M. E. S. A., Lotfy, A., Hassan, S. A., Elhak, S. A. D., Sobh, M. A., 2019. Fluoxetine induces direct inhibitory effects on mesenchymal stem cell derived osteoprogenitor cells independent of serotonin concentration. Mol Med Rep.19, 2611-2619. DOI: 10.3892/mmr.2019.9924.
Lauder, J. M., Zimmerman, E. F., 1988. Sites of serotonin uptake in epithelia of the developing mouse palate, oral cavity, and face: possible role in morphogenesis. J Craniofac Genet Dev Biol. 8, 265-276.
Lauder, J. M., Wilkie, M. B., Wu, C., Singh, S., 2000. Expression of 5-HT2A, 5-HT2B and 5-HT2C receptors in the mouse embryo. Int J Dev Neurosci. 18, 653–662. DOI: https://doi.org/10.1016/S0736-5748(00)00032-0.
Losso, E. M., Nicolau, J., 2003. Lactate dehydrogenase isoenzymes in dental pulp of rats according to stage of root development. Braz Dent J. 14, 5-11. DOI: http://dx.doi.org/10.1590/S0103-64402003000100001.
Mendes-da-Silva, C., De Souza, S. L., Barreto-Medeiros, J. M., Freitas-Silva, S. R., Antunes, D. E. C., Cunha, A. D. U., Ribas, V. R., De França, M. F. S., Nogueira, M. I., Manhães-de-Castro, R., 2002. Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats. Arq Neuro-Psiquiatr. 60, 928-931. DOI: http://dx.doi.org/10.1590/S0004-282X2002000600008.
Moiseiwitsch, J. R. D., Lauder, J. M., 1996. Stimulation of murine tooth development in organotypic culture by the neurotransmitter serotonin. Arch Oral Biol. 41, 161-165. DOI: https://doi.org/10.1016/0003-9969(95)00117-4.
Moiseiwitsch J. R. D., Raymond J. R., Tamir H., Lauder J. M., 1998. Regulation by serotonin of tooth-germ morphogenesis and gene expression in mouse mandibular explant cultures. Arch Oral Biol. 43, 789-800. DOI: https://doi.org/10.1016/S0003-9969(98)00067-3.
Moiseiwitsch, J. R. D., 2000. The role of serotonin and neurotransmitters during craniofacial development. Crit Rev Oral Biol. 11, 230-239. DOI: 10.1177/10454411000110020601.
Morrison, J. L., Riggs, K. W., Rurak, D.W., 2005. Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev. 17, 641-650. DOI: https://doi.org/10.1071/RD05030.
Oberlander, T. F., Gingrich, J. A., Ansorge, M. S., 2009. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 86, 672–677. DOI: 10.1038/clpt.2009.201.
Pawloski J. L., Charlier T. D., Fillet M., Houbart V., Crispin H. T., Steinbusch H. W., Van den Hove D. L., 2012. Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam. Behav Brain Res. 228, 159-168. DOI: https://doi.org/10.1016/j.bbr.2011.11.043.
Regueira, L. S., Correia-Leite de Marcelos, P. G., Santiago-Jaegger, I. M., Perez, D. E. C., Ramos-Perez, F. M. M., Neto, J. E., Baratella-Evêncio, L., 2017. Fluoxetine effects on periodontogenesis: histomorphometrical and immunohistochemical analyses in rats. J Appl Oral Sci. 25, 159-167. DOI: http://dx.doi.org/10.1590/1678-77572015-0564.
Sakakura, Y., Fujiwara, N., Sugawara, M., Nawa, T., 1989. In vitro effects of calcitonin and/or parathyroid hormone on odontogenesis of mouse embryonic molars. J Dent Res. 68, 1279-1284. DOI: 10.1177/00220345890680081301.
Santiago I. M. A., Regueira L. S., Correia P. G., Alcântara R. J. B., Evêncio-Neto J., Baratella-Evêncio L., 2013. Morphological aspects of dentin-pulp complex development in the offspring of rats treated with fluoxetine during pregnancy. Braz J Oral Sci. 12, 30-36. DOI: http://dx.doi.org/10.1590/S1677-32252013000100007.
Silva, I.H.M., Carneiro Leão,J, Baratella-Evêncio, L., Porter,S.R., de Castro, R.M., 2010. Morphological analysis of the enamel organ in rats treated with fluoxetine. Clinics. 65, 61-65. DOI: 10.1590/S1807-59322010000100010.
Sit D., Perel J. M., Wisniewski S. R., Helsel J. C., Luther J. F., Wisner K. L., 2011. Mother-infant antidepressant levels, maternal depression and perinatal events. J Clin Psychiatry. 72, 994-1001. DOI: 10.4088/JCP.10m06461.
Tecott, L., Shtrom, S., Julius, D., 1996. Expression of a serotonin-gated ion channel in embryonic neural and nonneural tissues. Mol Cell Neurosci. 6, 43-55. DOI: https://doi.org/10.1006/mcne.1995.1005.
Tredwin, C.J., Scully, C., Bagan-Sebastian, J.V., 2005. Drug-induced disorders of teeth. J Dent Res. 84, 596-602. DOI: 10.1177 / 154405910508400703.
Vilela, A.B.S., Costa, J.R.V., Lopes, R.A., Sala, M., 2001. Acción de la hipervitaminosis a en el germen dentario de fetos de rata: estudio histológico y morfométrico. Rev Chil Anat. 19, 231-238. DOI: 10.4067/S0716-98682001000300001.
Yokohama-Tamaki, T., Oshima, H., Fujiwara, N., Takada, Y., Ichimori, Y., Wakisaka, S., Ohuchi, H., Harada, H., 2006. Cessation of Fgf10 signaling, resulting in a defective dental epithelial stem cell compartment, leads to the transition from crown to root formation. Devel. 133, 1359-1366. DOI: 10.1242/dev.02307.
